Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 12, 2025 4
4 Jun 12, 2025 4
4 Jun 12, 2025 4
8-K Jun 11, 2025 8-K
10-Q May 14, 2025 10-Q
8-K May 6, 2025 8-K
ARS Apr 25, 2025 ARS
DEFA14A Apr 25, 2025 DEFA14A
DEF 14A Apr 25, 2025 DEF 14A
4 Apr 18, 2025 4
3 Apr 18, 2025 3
8-K Apr 17, 2025 CURRENT REPORT
SCHEDULE 13G/A Apr 7, 2025
4 Apr 7, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Apr 3, 2025 8-K
10-K/A Mar 28, 2025 10-K/A
4 Mar 6, 2025 4
4 Mar 6, 2025 4
S-8 Feb 28, 2025 S-8
10-K Feb 28, 2025 10-K
8-K Nov 18, 2024 CURRENT REPORT
SC 13G/A Nov 14, 2024 SC 13G/A
10-Q Nov 7, 2024 10-Q
4 Oct 21, 2024 4
8-K Oct 3, 2024 CURRENT REPORT
← Newer Page 3 of 26 · 646 filings Older →